Novelix Pharmaceuticals Ltd (NOVE)

Currency in INR
73.72
+3.22(+4.57%)
Closed·
Advertisement
NOVE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
71.0073.98
52 wk Range
38.0092.00
Key Statistics
Bid/Ask
72.00 / 73.50
Prev. Close
73.72
Open
71
Day's Range
71-73.98
52 wk Range
38-92
Volume
5.38K
Average Volume (3m)
10K
1-Year Change
83.1553%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NOVE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Earnings

Latest Release
29/05/2026
EPS / Forecast
0.32 / --
Revenue / Forecast
251.94M / --
EPS Revisions
Last 90 days

Compare NOVE to Peers and Sector

Metrics to compare
NOVE
Peers
Sector
Relationship
P/E Ratio
60.8x29.3x−0.4x
PEG Ratio
0.050.330.00
Price/Book
3.3x3.0x2.6x
Price / LTM Sales
1.2x3.8x3.0x
Upside (Analyst Target)
-7.7%50.7%
Fair Value Upside
Unlock3.1%7.2%Unlock

Novelix Pharmaceuticals Limited trades in pharmaceuticals and related products in India. It also trades in shares and securities; retails pharmaceuticals; and offers marketing services. The company was formerly known as Trimurthi Limited and changed its name to Novelix Pharmaceuticals Limited in October 2024. Novelix Pharmaceuticals Limited was incorporated in 1994 and is based in Hyderabad, India.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
11.02M52.25%776.67M
Public Companies & Retail Investors
10.07M47.75%709.83M
Total
21.08M100.00%1.49B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Srinidhi Fine-Chemicals LLP47.44%10,002,000705,141
Soura Investments Holdings Private Limited1.28%270,00019,035

FAQ

What Is the Novelix Pharmaceuticals (BSE: NOVE) Share Price Today?

The Novelix Pharmaceuticals stock price today is 73.72 INR.

What Stock Exchange Does Novelix Pharmaceuticals (NOVE) Trade On?

Novelix Pharmaceuticals is listed and trades on the Bombay Stock Exchange.

What Is the Ticker (Stock Symbol) for Novelix Pharmaceuticals?

The stock symbol (also called a 'ticker') for Novelix Pharmaceuticals is "NOVE."

What Is the Current Novelix Pharmaceuticals Market Capitalisation?

As of today, Novelix Pharmaceuticals (BSE: NOVE) market cap is 1.55B INR.

What Is Novelix Pharmaceuticals's (NOVE) Earnings Per Share (TTM)?

The Novelix Pharmaceuticals EPS is currently 1.21 (Trailing Twelve Months).

Is NOVE a Buy or Sell From a Technical Analyst Perspective?

Based on today's Novelix Pharmaceuticals moving averages and other technical indicators, the daily buy/sell signal for NOVE stock is Strong Buy.

How Many Times Has Novelix Pharmaceuticals Stock Split?

Novelix Pharmaceuticals has split 2 times. (See the NOVE stock split history page for full effective split date and price information.)

How Many Employees Does Novelix Pharmaceuticals Have?

Novelix Pharmaceuticals has 8 employees, based on their latest Companies House report.

What is the current trading status of Novelix Pharmaceuticals (BSE: NOVE)?

As of 07/08/2026, Novelix Pharmaceuticals (NOVE) is trading at a share price of 73.72 INR, with a previous close of 73.72 INR. The stock has fluctuated within a day range of 71.00 INR to 73.98 INR, while its 52-week range spans from 38.00 INR to 92.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.